860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K. Mehta(Dana-Farber Cancer Institute), Jennifer L. Guerriero(Brigham and Women's Hospital), Sandro Santagata(Harvard University), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Constantia Pantelidou(Harvard University), José Yélamos(Hospital Del Mar), Matthew J. Berberich(Harvard University), Christina Hartl(Io Therapeutics (United States)), Geoffrey I. Shapiro(Brigham and Women's Hospital), Aditi Kothari(Harvard University), Nadine Tung(Beth Israel Deaconess Medical Center), Jia‐Ren Lin(Harvard University), Sarah A. Boswell(Harvard University), Scott J. Rodig(Brigham and Women's Hospital), Mateus de Oliveira Taveira(Memorial Sloan Kettering Cancer Center), Peter K. Sorger(Harvard University Press), Deborah Dillon(Harvard University), Nathan Johnson(Harvard University), Mikel Lipschitz(Brigham and Women's Hospital), Madison Oliwa(Dana-Farber Cancer Institute), William M. Oldham(Brigham and Women's Hospital), Marian Kalocsay(The University of Texas MD Anderson Cancer Center), Jessica E. Thaxton(University of North Carolina at Chapel Hill), Katie E. Hurst(Medical University of South Carolina), Shawn F. Johnson(Harvard University), Emily Cheney(Dana-Farber Cancer Institute), Jessica A. Castrillon(Dana-Farber Cancer Institute), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 25